(Q38484362)

3 September 2017

title

Dynamic expression of miR-126* and its effects on proliferation and contraction of hepatic stellate cells (English)

1 reference

3 September 2017

12

Jing-Yuan Fang

1 reference

3 September 2017

Can-Jie Guo

1

1 reference

3 September 2017

Qin Pan

2

1 reference

3 September 2017

Hua Xiong

3

1 reference

3 September 2017

Yu-Qi Qiao

4

1 reference

3 September 2017

Zhao-Lian Bian

5

1 reference

3 September 2017

Wei Zhong

6

1 reference

3 September 2017

Li Sheng

7

1 reference

3 September 2017

Hai Li

8

1 reference

3 September 2017

Lei Shen

9

1 reference

3 September 2017

Jing Hua

10

1 reference

3 September 2017

Xiong Ma

11

1 reference

3 September 2017

language of work or name

English

0 references

publication date

16 October 2013

1 reference

3 September 2017

1 reference

3 September 2017

volume

587

1 reference

3 September 2017

issue

23

1 reference

3 September 2017

page(s)

3792-3801

1 reference

HSC-specific inhibition of Rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects.

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.09.047

Thymoquinone attenuates liver fibrosis via PI3K and TLR4 signaling pathways in activated hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.09.047

MicroRNA-281 regulates the expression of ecdysone receptor (EcR) isoform B in the silkworm, Bombyx mori

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.09.047

miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.09.047

Changes in microRNAs associated with hepatic stellate cell activation status identify signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.09.047

Effects of upregulated expression of microRNA-16 on biological properties of culture-activated hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.09.047

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.09.047

Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.09.047

Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.09.047

miR-126 and miR-126*: new players in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.09.047

The cell growth suppressor, mir-126, targets IRS-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.09.047

miR-126&126* restored expressions play a tumor suppressor role by directly regulating ADAM9 and MMP7 in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.09.047

miR-126 functions as a tumour suppressor in human gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.09.047

EGFL7 meets miRNA-126: an angiogenesis alliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.09.047

PTK787/ZK22258 attenuates stellate cell activation and hepatic fibrosis in vivo by inhibiting VEGF signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.09.047

Antifibrotic activity of rofecoxib in vivo is associated with reduced portal hypertension in rats with carbon tetrachloride-induced liver injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.09.047

Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: New targets for the treatment of portal hypertension?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.09.047

Attenuation of portal hypertension by natural taurine in rats with liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.09.047

MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.09.047

miR-181b promotes hepatic stellate cells proliferation by targeting p27 and is elevated in the serum of cirrhosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.09.047

Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.09.047

10.1016/J.FEBSLET.2013.09.047

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference